NFG
KYNB

Next Financial Group’s Kyntra Bio KYNB Stock Holding History

Next Financial Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$626K Buy
1,777
+137
+8% +$42.7K 0.04% 454
2021
Q3 		$419K Buy
1,640
+1,270
+343% +$450K 0.03% 537
2021
Q2 		$247K Buy
+370
New +$213K 0.02% 752
2020
Q1 		– Sell
-20
Closed -$21K – 2209
2019
Q4 		$21K Buy
20
+18
+900% +$18.4K ﹤0.01% 1503
2019
Q3 		$2K Sell
2
-1
-33% -$1.1K ﹤0.01% 2108
2019
Q2 		$3K Buy
+3
New +$3.28K ﹤0.01% 2007

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Next Financial Group's KYNB Position: Q4 2021 in Review

Next Financial Group increased its Kyntra Bio (KYNB) stake by 8.4% in Q4 2021, buying an estimated $42.7K and bringing the position to 1,777 shares worth $626K. The position accounts for 0.04% of the portfolio, ranked #454.

Next Financial Group first reported a position in KYNB in Q2 2019 and has held it in 6 quarters since. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Next Financial Group held 1,777 shares of Kyntra Bio worth $626K as of Q4 2021.
  • Next Financial Group bought 137 Kyntra Bio shares in Q4 2021, an estimated $42.7K.
  • Kyntra Bio made up 0.04% of Next Financial Group's portfolio in Q4 2021, its #454 holding.
  • Next Financial Group first reported a position in Kyntra Bio in Q2 2019 and has held it in 6 quarters since.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.